Cargando…

Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome

Detalles Bibliográficos
Autores principales:	Sinha, Rajiv, Marlais, Matko, Sarkar, Subhankar, Obukhova, Varvara, Lucchetti, Laura, Vasudevan, Anil, Chacon Jaimes, Diana Carolina, Weaver, Donald J., Stańczyk, Małgorzata, Lopez-Gonzalez, Mercedes, Schaefer, Franz, Tullus, Kjell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453467/ https://www.ncbi.nlm.nih.gov/pubmed/34548632 http://dx.doi.org/10.1038/s41390-021-01744-8

Ejemplares similares

The severity of COVID-19 in children on immunosuppressive medication
por: Marlais, Matko, et al.
Publicado: (2020)

Long-Term Efficacy and Safety of Rituximab Versus Tacrolimus in Children With Steroid Dependent Nephrotic Syndrome
por: Basu, Biswanath, et al.
Publicado: (2023)

Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth
por: Topaloğlu, Rezan, et al.
Publicado: (2019)

Rituximab treatment for difficult-to-treat nephrotic syndrome in children:a multicenter, retrospective study
por: TAŞDEMİR, Mehmet, et al.
Publicado: (2021)

Early Use of Rituximab in Calcineurin Inhibitor–Refractory and Steroid-Resistant Nephrotic Syndrome
por: Sinha, Rajiv, et al.
Publicado: (2020)

The effect of levamisole on kidney function in children with steroid-sensitive nephrotic syndrome
por: Hoogenboom, Lieke A., et al.
Publicado: (2021)

Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial
por: Mathew, Georgie, et al.
Publicado: (2022)

Rituximab for nephrotic syndrome in children
por: Iijima, Kazumoto, et al.
Publicado: (2016)

Rituximab Treatment for Nephrotic Syndrome in Children
por: Iijima, Kazumoto, et al.
Publicado: (2014)

Effectiveness of rituximab in nephrotic syndrome treatment
por: Popko, Katarzyna, et al.
Publicado: (2017)

Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
por: Basu, Biswanath, et al.
Publicado: (2020)

Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome: A multicenter open-label trial in Korea
por: Ahn, Yo Han, et al.
Publicado: (2018)

Intravenous Immunoglobulin and Methylprednisolone Refractory Multisystem Inflammatory Syndrome in Children (MIS-C) in Steroid-Dependent Nephrotic Syndrome Following Rituximab
por: Pal, Priyankar, et al.
Publicado: (2022)

Rituximab Use in the Management of Childhood Nephrotic Syndrome
por: Kallash, Mahmoud, et al.
Publicado: (2019)

High Incidence of COL4A Genetic Variants Among a Cohort of Children With Steroid-Resistant Nephrotic Syndrome From Eastern India
por: Sinha, Rajiv, et al.
Publicado: (2022)

Rituximab therapy in adults with steroid-dependent nephrotic syndrome
por: Zhong, Hongzhen, et al.
Publicado: (2019)

Should we screen for intracranial aneurysms in children with autosomal dominant polycystic kidney disease?
por: Walker, Emma Y. X., et al.
Publicado: (2022)

Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
por: Angeletti, Andrea, et al.
Publicado: (2022)

COVID-19 in children treated with immunosuppressive medication for kidney diseases
por: Marlais, Matko, et al.
Publicado: (2021)

Improved renal allograft survival for pre-emptive paediatric renal transplant recipients in the UK
por: Marlais, Matko, et al.
Publicado: (2021)

Rituximab in idiopathic nephrotic syndrome: still waiting for stronger evidences
por: Belangero, Vera Maria Santoro
Publicado: (2023)

Central blood pressure and measures of early vascular disease in children with ADPKD
por: Marlais, Matko, et al.
Publicado: (2019)

Clinico-pathological correlations of congenital and infantile nephrotic syndrome over twenty years
por: Kari, Jameela A., et al.
Publicado: (2014)

Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome
por: Counsilman, Clare E., et al.
Publicado: (2015)

Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
por: Grenda, Ryszard, et al.
Publicado: (2016)

Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
por: Iijima, Kazumoto, et al.
Publicado: (2017)

The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
por: Maratea, Dario, et al.
Publicado: (2016)

A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
por: Xu, Jing, et al.
Publicado: (2021)

Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
por: Song, Yiyun, et al.
Publicado: (2023)

Difficult Renal Pathological Classification in a Case of Pediatric Nephrotic Syndrome
por: Yamaguchi, Hiroshi, et al.
Publicado: (2017)

Targeting Tubulointerstitium to Predict Kidney Outcomes in Childhood Nephrotic Syndrome
por: Azukaitis, Karolis, et al.
Publicado: (2020)

Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan
por: Takura, Tomoyuki, et al.
Publicado: (2017)

PD42 - Is rituximab a trigger for persistent hypogammaglobulinemia in idiopathic nephrotic syndrome?
por: Trujillo, Juan Enrique, et al.
Publicado: (2014)

Kinetics of Rituximab Excretion into Urine and Peritoneal Fluid in Two Patients with Nephrotic Syndrome
por: Stahl, Klaus, et al.
Publicado: (2017)

Late-Onset Neutropenia after Rituximab Treatment for Adult-Onset Nephrotic Syndrome
por: Yamazaki, Mayuko, et al.
Publicado: (2019)

Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
por: Kim, Ji Hyun, et al.
Publicado: (2017)

Rituximab experience in children with nephrotic syndrome: what have we observed differently
por: Girişgen, İlknur, et al.
Publicado: (2020)

Children with Steroid Dependent Nephrotic Syndrome: Rituximab or Tacrolimus? It’s All in the Timing
por: Qader, Md Abdul, et al.
Publicado: (2023)

Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
por: Zurowska, Aleksandra, et al.
Publicado: (2023)

Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
por: Ma, Xiaoyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tqqe6c76bmojmhdsfd3fsijsgv